{"id":21360,"date":"2013-05-29T15:05:14","date_gmt":"2013-05-29T15:05:14","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=21360"},"modified":"2013-05-29T15:05:14","modified_gmt":"2013-05-29T15:05:14","slug":"fixed-dose-combination-efavirenztenofovirftc-for-south-africa","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/21360","title":{"rendered":"Fixed dose combination efavirenz\/tenofovir\/FTC for South Africa"},"content":{"rendered":"<p><strong>Polly Clayden, HIV i-Base<\/strong><\/p>\n<p><strong>After a considerable wait (and considerable campaigning), in 2012, the South African Minister of Health, announced the award of a new antiretroviral tender \u2013 worth R5.9 billion (\u00a3406,226,800).<\/strong><\/p>\n<p>For the first time since the ART programme began, the tender includes a triple fixed-dose combination (FDC). The FDC is efavirenz\/tenofovir\/FTC for first line treatment and it is anticipated that over 90% of new patients will be eligible to initiate this FDC, including pregnant women.<\/p>\n<p>Source:<\/p>\n<p>The Southern African Clinicians Society advice document. Fixed-dose combination for adults accessing antiretroviral therapy. SAHIVMED Vol 14, No 1 (2013).<br \/>\n<a href=\"http:\/\/www.sajhivmed.org.za\/index.php\/sajhivmed\/article\/view\/913\/798\">http:\/\/www.sajhivmed.org.za\/index.php\/sajhivmed\/article\/view\/913\/798<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Polly Clayden, HIV i-Base After a considerable wait (and considerable campaigning), in 2012, the South African Minister of Health, announced the award of a new antiretroviral tender \u2013 worth R5.9 billion (\u00a3406,226,800). For the first time since the ART programme &hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-21360","post","type-post","status-publish","format-standard","hentry","category-treatment-access"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/21360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=21360"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/21360\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=21360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=21360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=21360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}